Abstract PO1-07-05: Preliminary Evaluation in Breast Cancer of PointCheck: a Noninvasive AI-Based Neutropenia Monitoring Device
Juan Garcia(Instituto Oncológico Dr. Rosell), Azadeh Nasrazadani(The University of Texas MD Anderson Cancer Center), Ryan Benasutti, Toshiaki Iwase(University of Hawaiʻi at Mānoa), Manuel Alva(Hospital Universitario 12 De Octubre), Ganimete Lamaj, Alberto Pablo‐Trinidad(Kao Corporation (Spain)), Pablo Tolosa(Research Institute Hospital 12 de Octubre), Aurélien Bourquard, Álvaro Sánchez‐Ferro(Massachusetts Institute of Technology), Alejandro Martínez‐Bueno(Hospital Universitario Dexeus), Eva Ciruelos(Hospital Universitario 12 De Octubre), Carlos Castro‐González, José Manuel Pérez-García(MedSIR (Spain)), José Pelaez-Escobar(Kao Corporation (Spain)), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), I. Butterworth
Cited by 0
Related Papers
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684